CC Stock Overview
Provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 1/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
My Notes
Capture your thoughts, links and company narrative
The Chemours Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$16.83 |
| 52 Week High | US$29.83 |
| 52 Week Low | US$15.10 |
| Beta | 1.8 |
| 1 Month Change | -13.25% |
| 3 Month Change | -11.65% |
| 1 Year Change | -40.15% |
| 3 Year Change | -42.42% |
| 5 Year Change | -13.43% |
| Change since IPO | -15.98% |
Recent News & Updates
Chemours (NYSE:CC) Seems To Be Using A Lot Of Debt
Jan 24
Are Investors Undervaluing The Chemours Company (NYSE:CC) By 50%?
Jan 08Recent updates
Chemours (NYSE:CC) Seems To Be Using A Lot Of Debt
Jan 24Are Investors Undervaluing The Chemours Company (NYSE:CC) By 50%?
Jan 08Not Many Are Piling Into The Chemours Company (NYSE:CC) Just Yet
Dec 05Chemours: Hasn't Been A Great Year, But The Long-Term Prospects Look Bright
Nov 21Chemours' (NYSE:CC) Earnings Offer More Than Meets The Eye
Nov 12Is It Too Late To Consider Buying The Chemours Company (NYSE:CC)?
Sep 25Chemours: We're Back Down To Trough And A 'BUY'
Sep 01Chemours: Upside After Irregularities, Good 2024-2026E
Jun 11The Chemours Company's (NYSE:CC) Low P/S No Reason For Excitement
May 30Drama At The Chemours Company Opens The Door For Upside
Mar 29The Chemours Company (NYSE:CC) Not Doing Enough For Some Investors As Its Shares Slump 37%
Mar 01Chemours: The Case Amidst Board Trouble, I Say Buy The Weakness
Feb 29Chemours (NYSE:CC) Has Announced A Dividend Of $0.25
Feb 17Chemours: Technological Innovation Presents Excellent Opportunities For Growth
Dec 23Chemours (NYSE:CC) Will Pay A Dividend Of $0.25
Oct 30The Chemours Company (NYSE:CC) Shares Could Be 21% Above Their Intrinsic Value Estimate
Oct 28Chemours: Volatile Bottom Line Needs Consistency
Oct 06The Chemours Company: Portfolio Optimization Resulting In Compounding Growth
Sep 19Chemours (NYSE:CC) Takes On Some Risk With Its Use Of Debt
Jul 18Is There An Opportunity With The Chemours Company's (NYSE:CC) 48% Undervaluation?
Jul 03The Chemours Company: On A Nice Run
Jul 03Shareholder Returns
| CC | US Chemicals | US Market | |
|---|---|---|---|
| 7D | -7.8% | 1.5% | 1.5% |
| 1Y | -40.1% | 2.6% | 22.4% |
Return vs Industry: CC underperformed the US Chemicals industry which returned 2.6% over the past year.
Return vs Market: CC underperformed the US Market which returned 22.4% over the past year.
Price Volatility
| CC volatility | |
|---|---|
| CC Average Weekly Movement | 6.6% |
| Chemicals Industry Average Movement | 4.9% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in US Market | 18.0% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CC has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: CC's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 6,200 | Denise M. Dignam | www.chemours.com |
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.
The Chemours Company Fundamentals Summary
| CC fundamental statistics | |
|---|---|
| Market cap | US$2.51b |
| Earnings (TTM) | US$76.00m |
| Revenue (TTM) | US$5.75b |
33.1x
P/E Ratio0.4x
P/S RatioIs CC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CC income statement (TTM) | |
|---|---|
| Revenue | US$5.75b |
| Cost of Revenue | US$4.62b |
| Gross Profit | US$1.13b |
| Other Expenses | US$1.06b |
| Earnings | US$76.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 18, 2025
| Earnings per share (EPS) | 0.51 |
| Gross Margin | 19.71% |
| Net Profit Margin | 1.32% |
| Debt/Equity Ratio | 605.8% |
How did CC perform over the long term?
See historical performance and comparisonDividends
5.9%
Current Dividend Yield196%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/16 09:53 |
| End of Day Share Price | 2025/02/14 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
The Chemours Company is covered by 20 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Alembic Global Advisors |
| David Coleman | Argus Research Company |
| Ishan Majumdar | Baptista Research |